Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?'. Together they form a unique fingerprint.

Medicine & Life Sciences